Skip to main content
  • Sections
  • Search

Center for Strategic & International Studies

User menu

  • Subscribe
  • Sign In

   Ranked #1 Think Tank in U.S. by Global Go To Think Tank Index

Topics

  • Climate Change
  • Cybersecurity and Technology
    • Cybersecurity
    • Data Governance
    • Intelligence, Surveillance, and Privacy
    • Military Technology
    • Space
    • Technology and Innovation
  • Defense and Security
    • Counterterrorism and Homeland Security
    • Defense Budget
    • Defense Industry, Acquisition, and Innovation
    • Defense Strategy and Capabilities
    • Geopolitics and International Security
    • Long-Term Futures
    • Missile Defense
    • Space
    • Weapons of Mass Destruction Proliferation
  • Economics
    • Asian Economics
    • Global Economic Governance
    • Trade and International Business
  • Energy and Sustainability
    • Energy, Climate Change, and Environmental Impacts
    • Energy and Geopolitics
    • Energy Innovation
    • Energy Markets, Trends, and Outlooks
  • Global Health
    • Family Planning, Maternal and Child Health, and Immunizations
    • Multilateral Institutions
    • Health and Security
    • Infectious Disease
  • Human Rights
    • Civil Society
    • Transitional Justice
    • Human Security
  • International Development
    • Food and Agriculture
    • Governance and Rule of Law
    • Humanitarian Assistance
    • Private Sector Development
    • U.S. Development Policy

Regions

  • Africa
    • North Africa
    • Sub-Saharan Africa
  • Americas
    • Caribbean
    • North America
    • South America
  • Arctic
  • Asia
    • Afghanistan
    • Australia, New Zealand & Pacific
    • China
    • India
    • Japan
    • Korea
    • Pakistan
    • Southeast Asia
  • Europe
    • European Union
    • NATO
    • Post-Soviet Europe
    • Turkey
  • Middle East
    • The Gulf
    • Egypt and the Levant
    • North Africa
  • Russia and Eurasia
    • The South Caucasus
    • Central Asia
    • Post-Soviet Europe
    • Russia

Sections menu

  • Programs
  • Experts
  • Events
  • Analysis
    • Blogs
    • Books
    • Commentary
    • Congressional Testimony
    • Critical Questions
    • Interactive Reports
    • Journals
    • Newsletter
    • Reports
    • Transcript
  • Podcasts
  • iDeas Lab
  • Transcripts
  • Web Projects

Main menu

  • About Us
  • Support CSIS
    • Securing Our Future
Blog Post - Smart Global Health
Share
  • LinkedIn
  • Facebook
  • Twitter
  • Email
  • Printfriendly.com

Reproductive Health Choices for People Living with HIV/AIDS in Developing Countries

July 27, 2010

Phillip Nieburg
Senior Associate, Global Health Policy Center, CSIS

Since the early 1990s, many Americans have learned a lot about the cultures and health problems of various developing countries through reading and hearing about the spread and consequences of HIV/AIDS in those countries.  However, one particular developing country HIV/AIDS dilemma that requires more attention in global AIDS policy and that has not been highlighted at the 18th International AIDS Conference in Vienna is the set of complex reproductive health decisions faced by HIV-infected women or by couples, at least one of whom is infected by HIV.

HIV-infected and wanting to become pregnant

A subgroup of people living with HIV/AIDS (PLWHA) is those people who are not yet pregnant, but who want to have a child. In industrialized countries, with relatively easy access to anti-retroviral drugs and to various kinds of assisted reproductive technologies, the odds of such PLWHA completing a pregnancy that results in an uninfected child are very good. 

In contrast, pregnancy planning among HIV-infected women living in developing countries present a far more complex set of issues. 

While there is considerable societal pressure on women in most developing countries to have children, some non-pregnant women who know that they are infected with HIV but still want to bear a child are subjected to strong social pressures not to do so - by families, by communities, and by health care providers. In some cases, women face even more extreme forms of resistance such as the coerced sterilization recently documented among a group of HIV-infected women in Namibia. Still other HIV-infected women desiring to have a child may be lucky enough to have access to a specialized antenatal program that can provide them and their newborns with the kind of care and anti-retroviral medicines that can markedly reduce their children’s risk of becoming infected with HIV, while also ensuring that the mothers have access to HIV treatment for themselves. The coverage and effectiveness of such specialized programs for the prevention of mother-to-child transmission (PMTCT)  – and their linkage to routine family planning, antenatal programs, and HIV treatment – is still sporadic but growing, and these programs deserve targeted support.

HIV-infected and not wanting to become pregnant

For non-pregnant HIV-infected women who do not want to become pregnant or who want to space their pregnancies, their ability to make that kind of planning decision in most developing countries depends on their relationships with their spouses or other sexual partners and on their access to – and ability to use - adequate forms of contraception.

Already pregnant and HIV-infected

Because the frequency of HIV testing and counseling is still low in many developing countries, a far more common scenario in those countries is for women to find out that they are HIV-infected only after they are pregnant, when they are tested for HIV as a component of their routine antenatal care.    

That situation – HIV diagnosis after becoming pregnant – presents an even more complex and more difficult set of choices. First, the shock of finding out that they are infected with an ultimately fatal and highly stigmatized disease presents each one with an almost overwhelming set of concerns, e.g., How did they become infected? What will happen to them if they disclose their status to their partner? Will they be blamed for bringing the virus into the household, even if they were infected by their partner? What does it mean for their future? Can their baby be protected? What does it mean for their baby’s future? How can their disease be treated? Will their family support them? Some of these women may have access to the kind of PMTCT program described earlier and can hope to have an uninfected child.  Many will not have such access.

Even with access to adequate counseling and PMTCT services, the reality is that, fearing for their own future and their children’s future, many such women will not want to continue their pregnancies and will seek pregnancy termination. Many of these women will put themselves at risk of death or other severe sequelae because their only choice is an unsafe abortion.                  

Although presented only in abbreviated form, these various HIV and pregnancy scenarios obviously raise a set of complex and partially overlapping public policy issues for any individuals and organizations concerned with HIV prevention and with maternal and child health in developing countries. For example: (1) How can overall HIV prevention efforts be accelerated so as to minimize the number of people in developing countries who find an HIV infection complicating their childbearing decisions? (2) How can the HIV testing and counseling process be improved so that more people know their own and their sex partner’s HIV status before pregnancy becomes an issue? (3) How can HIV-related stigma be best addressed? (4) How can the access of HIV-infected women to effective contraceptive be improved as part of HIV treatment programs? (5) How can the coverage and effectiveness of PMTCT programs be improved? (6) How can the exposure of women to unsafe abortion be reduced so as to further decrease maternal mortality?

Policy decisions made both in developing countries themselves and in the United States and other donor nations will help answer these questions.      

Related Content

  • An Important Success in HIV Prevention Research - and the Need for a Lot More Work
  • Integrating HIV with Other Health Services for Women: New Models in Kenya
  • The Future of Global HIV Treatment and Prevention
Media Queries

Contact H. Andrew Schwartz
Chief Communications Officer
Tel: 202.775.3242

Contact Caleb Diamond
Media Relations Manager and Editorial Associate
Tel: 202.775.3173

More from this blog

Blog Post
U.S.-Japan Dialogue: Strengthening the Partnership on Global Health
By J. Stephen Morrison
In Smart Global Health
July 25, 2017
Blog Post
Yellow Fever in Brazil: The Latest Global Health Security Threat
In Smart Global Health
June 23, 2017
Blog Post
Brazil's Sistema Único da Saúde (SUS): Caught in the Cross Fire
By Katherine E. Bliss
In Smart Global Health
June 21, 2017
Blog Post
GPEI’s Funding Decline Among Tedros’ Top Challenges as WHO Director-General
By Nellie Bristol
In Smart Global Health
June 9, 2017
Blog Post
Achieving TB Milestones Through Last Mile Delivery in India
In Smart Global Health
May 25, 2017
Blog Post
Training the Informal Health Workforce in India
In Smart Global Health
May 22, 2017
Blog Post
What’s to Be Done to End the Opioid Epidemic?
In Smart Global Health
May 19, 2017
Blog Post
New Partnerships Needed after Ebola's Hard Lessons
By J. Stephen Morrison
In Smart Global Health
April 25, 2017

Related Content

Commentary
Renewing Global Commitments to Pediatric HIV within the Covid-19 Response
By Katherine E. Bliss
December 1, 2020
Commentary
The World’s Largest HIV Epidemic in Crisis: HIV in South Africa
By Sara M. Allinder, Janet Fleischman
April 2, 2019
Commentary
Time to Address the Intersecting Crises of Covid-19, HIV, and Gender Inequality
By Janet Fleischman
November 30, 2020
Commentary
From Crisis to Inclusion: The Story of Venezuela’s Women
By Arianna Kohan, Moises Rendon
March 4, 2020
Report
Challenges to Continued U.S. Leadership Ahead of Global HIV’s Next Phase
By Sara M. Allinder
May 28, 2020
Commentary
A New Covid-19 Mantra? 'Nobody Is Safe until Everybody Is Fed'
By Chase Sova
December 4, 2020
Commentary
World AIDS Day: Big Questions on the Eve of HIV’s Pivotal Year
By Sara M. Allinder
November 26, 2019
Report
The Evolution and Future of HIV Prevention Technology: An HIV Policy Primer
By Sara M. Allinder
October 21, 2019
Footer menu
  • Topics
  • Regions
  • Programs
  • Experts
  • Events
  • Analysis
  • Web Projects
  • Podcasts
  • iDeas Lab
  • Transcripts
  • About Us
  • Support Us
Contact CSIS
Email CSIS
Tel: 202.887.0200
Fax: 202.775.3199
Visit CSIS Headquarters
1616 Rhode Island Avenue, NW
Washington, DC 20036
Media Queries

Contact H. Andrew Schwartz
Chief Communications Officer
Tel: 202.775.3242

Contact Caleb Diamond
Media Relations Manager and Editorial Associate
Tel: 202.775.3173

Daily Updates

Sign up to receive The Evening, a daily brief on the news, events, and people shaping the world of international affairs.

Subscribe to CSIS Newsletters

Follow CSIS
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

All content © 2020. All rights reserved.

Legal menu
  • Credits
  • Privacy Policy
  • Reprint Permissions